SyncoZymes

litaba

Tsoelo-pele ea lipatlisiso mabapi le tlhahiso ea enzyme ea li-precursors tse ka bang teng tsa Clenbuterol ka tšebelisano-'moho pakeng tsa Univesithi ea Saense le Theknoloji ea Norway le Shangke Biomedical

Clenbuterol, ke agonist ea β2-adrenergic (agonist ea β2-adrenergic), e tšoanang le ephedrine (Ephedrine), hangata e sebelisoa ka bongaka ho phekola lefu le sa foleng la matšoafo (COPD), E boetse e sebelisoa e le bronchodilator ho imolla ho mpefala ha asma. Mathoasong a bo-1980, k'hamphani ea Amerika ea Cyanamid e ile ea fumana ka phoso hore e na le litlamorao tse totobetseng tsa ho khothaletsa kholo, ho ntlafatsa sekhahla sa nama e se nang mafura le ho fokotsa mafura, kahoo e ile ea sebelisoa e le clenbuterol ho rueng liphoofolo. Leha ho le joalo, ka lebaka la litla-morao tsa eona, Sechaba sa Europe se ile sa thibela tšebeliso ea clenbuterol e le tlatsetso ea lijo ho tloha ka la 1 Pherekhong, 1988. E ile ea thibeloa ke FDA ka 1991. Ka 1997, Lefapha la Temo la Rephaboliki ea Batho ba Chaena le ile la thibela ka tieo tšebeliso ea lihormone tsa beta-adrenergic tlhahisong ea lijo le tlhokomelo ea liphoofolo, 'me Clenbuterol hydrochloride e ile ea beha boemo ba pele.

Leha ho le jwalo, Clenbuterol ya racemic e sa tswa bontshwa hore e fokotsa kotsi ya lefu la Parkinson. Ho netefatsa hore na ke di-isomer dife (kapa ka bobedi) tse hlahisang phello ena, enantiomer e hlwekileng ya Clenbuterol e hloka ho ithutwa ka thoko.

Sehloohong sa morao tjena, sehlopha sa lipatlisiso sa Elisabeth Egholm Jacobsen oa Lefapha la Khemistri, Univesithi ea Saense le Theknoloji ea Norway, ka tšebelisano-'moho le Ngaka Zhu Wei oa Shangke Bio, se susumelitse tlhahiso ea ketoreductase KRED le cofactor nicotinamide adenine dinucleoside phosphate (NADPH). (R)-1-(4-Amino-3,5-dichlorophenyl)-2-bromoethan-1-ol, ee > 93%; le (S)-N-(2) li entsoe ka sistimi e tšoanang ,6-Dichloro-4-(1-hydroxyethyl)phenyl)acetamide, ee >98%. Li-intermediate tse kaholimo ka bobeli ke li-precursor tse ka bang teng tsa li-isomer tsa clenbuterol. Ketoreductase ES-KRED-228 e sebelisitsoeng thutong ena e ne e tsoa ho Shangke Biopharmaceutical (Shanghai) Co., Ltd. Sephetho sa lipatlisiso "Chemoenzymatic Synthesis of Synthons as Precursors for Enantiopure Clenbuterol and Other -2-Agonists" se phatlalalitsoe ho "Catalysts" ka la 4 Pulungoana, 2018.

Tsoelo-pele ea lipatlisiso mabapi le tlhahiso ea li-enzyme

Nako ea poso: Phato-26-2022